# JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study

> **NCT01105780** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** JNJ-41443532

## Key facts

- **NCT ID:** NCT01105780
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** —
- **Final completion:** 2010-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01105780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01105780, "JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01105780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*